L-asparaginase biosimilar (Claris Lifesciences)

L-天冬酰胺酶生物类似药 (Claris Lifesciences)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameL-asparaginase biosimilar (Claris Lifesciences)
Drug Alias NameL-天冬酰胺酶生物仿制药 (Claris Lifesciences)Engenase
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionAsparaginase stimulants
TargetsAsparaginase
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesClaris Lifesciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClaris Lifesciences Ltd
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeL01XX02
Related LinksN/A